Structural studies of aldo-keto reductase inhibition

Advances in Experimental Medicine and Biology

Volumn 414, Issue , 1997, Pages 435-442

  Wilson, David K ^a   Nakano, Takayuki ^b   Petrash, J Mark ^b   Quiocho, Florante A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; ZOPOLRESTAT;

CONFERENCE PAPER; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME INHIBITOR COMPLEX; ENZYME INHIBITOR INTERACTION; ENZYME MECHANISM; ENZYME PURIFICATION; ENZYME STRUCTURE; INHIBITION KINETICS; PRIORITY JOURNAL;

ALDEHYDE REDUCTASE; BENZOTHIAZOLES; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; ENZYME INHIBITORS; HUMANS; MODELS, STRUCTURAL; NADP; PHTHALAZINES; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; THIAZOLES;

EID: 0030943362     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (21)

1. Bohren KM, Grimshaw CE, Lai CJ, Harrison DH, Ringe D, Petsko GA, Gabbay KH. (1994) Tyrosine-48 is the proton donor and histidine-110 directs substrate stereochemical selectivity in the reduction reaction of human aldose reductase: enzyme kinetics and crystal structure of the Y48H mutant enzyme. Biochemistry 33:2021-3032.
2. Borhani DW, Harter TM, Petrash JM. (1992) The crystal structure of the aldose reductase - NADPH binary complex. J. Biol. Chem. 267:24841-24847.
3. Bruenger AT. (1992) XPLOR: A system for crystallography and NMR. Version 3.1 Manual, Yale University Press, New Haven CT.
4. Donohue PJ, Alberts GF, Hampton BS, Winkles JA. (1994) A delayed-early gene activated by fibroblast growth factor-1 encodes a protein related to aldose reductase. J. Biol. Chem. 269:8604-8609.
5. Dvornick D, Simard-Duguesne N, Kraml M, Sestanj K, Gabbay KH, Kinoshita JH, Varma DS, Merola LO. Polyol accumulation in galactosaemic and diabetic rats: control by an aldose reductase inhibitor. Science 182:1146-1148.
6. El-Kabbani O, Green NC, Lin G, Carson M, Narayanam SVL, Moore K, Flynn TG, DeLucas LJ. (1994) Structures of human and porcine aldehyde reductase: an enzyme implicated in diabetic complications. Ada Crystallogr. D50:859-868.
7. El-Kabbani O, Judge K, Ginell SL, Myles D, DeLucas LJ, Flynn TG. (1995) Structure of porcine aldehyde reductase holoenzyme. Nat. Struct. Biol. 2:687-692.
8. Farber GK, Petsko GA. (1990) The evolution of α/β barrel enzymes. Trends Biochem. Sci. 15:228-234.
9. Hoog SS, Pawlowski JE, Alzari PM, Penning TM, Lewis M. (1994) Three-dimensional structure of rat liver 3α-hydroxysteroid/dihydrodiol dehydrogenase: a member of the aldo-keto reductase superfamily. Proc. Natl. Acad. Sci. U.S.A. 91:2517-2521.
10. Kador PF, Lee YS, Rodriguez L, Sato S, Bartoszko-Malik A, Abdel-Ghany YS, Miller DD. (1995) Identification of an aldose reductase inhibitor site by affinity labeling. Bioorg. Med. Chem. 3:1313-1324.
11. Kraulis PJ. (1991) MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystall. 24:946-950.
12. Mylari BL, Larson ER, Beyer TA, Zembrowski WJ, Aldinger CE, Dee MF, Siegel TW, Singleton DH. (1991) Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-1- phthalazine-acetic acid (zopolrestat) and congeners. J. Med. Chem. 35:457-465.
13. Petrash JM, Harter TM, Devine CS, Olins PO, Bhatnagar A, Liu S, Srivastava SK. (1992) Involvement of cysteine residues in catalysis and inhibition of human aldose reductase: site directed mutagenesis of cys-80, cys-298 and cys-303. J. Biol. Chem. 267:24833-24840.
14. Rondeau JM, Tete-Favier F, Podjarny A, Reymann JM, Barth P, Biellmann JF, Moras D. (1992) Novel NADPH-binding domain revealed by the crystal structure of aldose reductase. Nature 355:469-472.
15. Sarges R, Oates P. (1993) Aldose reductase inhibitors: recent developments. Prog. Drug Res. 40:99-161.
16. Shoichet BK, Kuntz ID. (1993) Matching chemistry and shape in molecular docking. Prot. Eng. 6:723-732.
17. Tarie I, Borhani DW, Wilson DK, Quiocho FA, Petrash JM. (1993) Probing the active site of human aldose reductase: site directed mutagenesis of asp-43, tyr-48, lys-77 and his-110. J. Biol Chem. 268:25687-25693.
18. Wilson DK, Bohren KM, Gabbay KH, Quiocho FA. (1992) An unlikely sugar substrate site in the 1.65 Å structure of the human aldose reductase holoenzyme implicated in diabetic complications. Science 257:81-84.
19. Wilson DK, Tarle I, Petrash JM, Quiocho FA. (1993) Refined 1.8 Å structure of human aldose reductase complexed with the potent inhibitor zopolrestat. Proc. Natl. Acad. Sci. U.S.A. 90:9847-9851.
20. Wilson DK, Nakano T, Petrash JM, Quiocho FA. (1995) 1.7 Å structure of FR-1, a fibroblast growth factor-induced member of the aldo-keto reductase family complexed with coenzyme and inhibitor. Biochemistry 34:14323-14330.
21. Lee YS, Hodoscek M, Brooks B, Kador PF (1996) Investigation of the geometry of asp-43, lys-77, tyr-48 and his-110 in the active site of human aldose reductase by the QM/MM potential, in the 8th International Workshop for Enzymology and Molecular Biology of Carbonyl Metabolism. Deadwood, South Dakota, June 29 - July 3, 1996.